T1	p 22 70	endoscopic retrograde cholangiopancreatography :
T2	p 167 180	anesthetist .
T3	p 239 296	endoscopic retrograde cholangiopancreatography ( ERCP ) .
T4	p 381 394	' experiences
T5	p 420 441	sedation ( PCS ) with
T6	p 497 498	)
T7	p 501 530	or the department 's standard
T8	p 620 656	The study included 281 adults in 301
T9	p 668 669	.
T10	p 674 685	PCS group (
T11	p 785 792	group (
T12	p 797 800	100
T13	p 1058 1069	PCS and ACS
T14	p 1181 1202	( ACS n = 0 ; PCS n =
T15	p 1246 1276	more deeply sedated patients (
T16	p 1308 1309	,
T17	p 1333 1337	than
T18	p 1346 1359	and midazolam
T19	p 1435 1444	PCS . PCS
T20	p 1517 1543	preference for PCS and ACS
T21	p 1570 1587	PCS with propofol
T22	p 1631 1636	ACS .
T23	i 6 14	Sedation
T24	i 22 68	endoscopic retrograde cholangiopancreatography
T25	i 104 140	patient-controlled propofol sedation
T26	i 156 180	by a nurse anesthetist .
T27	i 239 292	endoscopic retrograde cholangiopancreatography ( ERCP
T28	i 401 419	patient-controlled
T29	i 442 492	propofol , nurse anesthetist-controlled sedation (
T30	i 534 550	care , midazolam
T31	i 589 594	group
T32	i 723 737	mg of propofol
T33	i 819 830	of propofol
T34	i 917 943	Alertness/Sedation ( OAA/S
T35	i 992 1001	midazolam
T36	i 1162 1182	midazolam sedation (
T37	i 1207 1218	midazolam n
T38	i 1350 1359	midazolam
T39	i 1579 1587	propofol
T40	i 1603 1612	midazolam
T41	o 6 14	Sedation
T42	o 223 231	sedation
T43	o 250 294	retrograde cholangiopancreatography ( ERCP )
T44	o 328 354	safety , ease of treatment
T45	o 357 365	recovery
T46	o 459 481	anesthetist-controlled
T47	o 766 774	sedation
T48	o 861 869	sedation
T49	o 876 881	level
T50	o 891 899	Observer
T51	o 917 935	Alertness/Sedation
T52	o 938 953	OAA/S ) scale .
T53	o 1084 1095	ease of the
T54	o 1122 1149	number of sedation failures
T55	o 1277 1292	OAA/S level 2 )
T56	o 1295 1309	desaturation ,
T57	o 1377 1411	full recovery ( Aldrete score ?9 )
T58	o 1461 1483	least fatigue and pain
T59	o 1672 1702	fewer respiratory events , and